| Model Number |
ADVIA CHEMISTRY XPT - LIPASE (LIP) |
| Medical Device Problem Code |
Imprecision (1307)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
12/12/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Siemens healthcare diagnostics, inc.Has received customer complaints regarding failed calibrations and increased imprecision of quality control and patient samples when using advia chemistry lipase reagent lot 485700.Preliminary investigation has indicated that not all cartons within this reagent lot are impacted.An urgent medical device recall (umdr) chc 20-03.A.Us was sent to us customers and an urgent field safety notice (ufsn) chc 20-03.A.Ous was sent to ous customers in december 2019.The umdr and ufsn advise customers of the investigation with the advia chemistry lipase reagent lot 485700 and provide instructions to help determine if the lipase reagent cartons in their inventory are impacted.If the cartons in the customers inventory are not impacted, the customers are instructed to proceed to using the cartons according to the instructions for use.If the cartons in the customers inventory are impacted, the customers are instructed to discard the impacted cartons and can request replacement.The next reagent lot is expected to be available by february 2020.If replacement kits are not available, customers are instructed to test patient samples using an alternate methodology.
|
| |
|
Event or Problem Description
|
|
The customer obtained imprecise lipase (lip) patient and quality control (qc) results while using advia chemistry xpt and the customer also saw high imprecision for rbl value of calibration with lot #485700.The initial and repeat patient results were not reported to the physician(s).The customer used patient serum samples that were already resulted with previous lip lots to assess the precision of lip lot 485700 on advia chemistry.The customer also performed a lot-to-lot, instrument-to-instrument comparison with both qc and patient samples to investigate the observed imprecision.There are no known reports of patient intervention or adverse health consequences due to the discordant lip results.
|
| |
|
Search Alerts/Recalls
|